The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
New Generation Nanogold and Nanosilver Polymer Composites and Their Applications
Zone of inhibition for Staphylococcus aureus bacteria (clear area) around a nanosilver-polyurethane bead (removed) that was positioned on the surface of an inoculated agar plate, as shown by the arrows.
School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand
NSTI Online Community